91影库

Journal News

Review delves into proximity proteomics

Laurel Oldach
April 20, 2020

In a recent in Molecular & Cellular Proteomics, Payman Samavarchi–Tehrani and colleagues in the at Sinai Health Systems and the University of Toronto offer an introduction to proximity-dependent biotinylation, a key first step in proximity proteomics. The authors give researchers who are new to the field information about the natural history of biotinylation enzymes. They also offer insights into the mechanisms of these enzymes and new perspectives on future proximity proteomics experiments.

Traditional proteomics can provide information about the quantitative contents of a cell or tissue, but it sacrifices much information on the spatial organization of proteins within cells. Since protein activity often depends on location and interactions with other proteins, researchers have developed approaches such as proximity proteomics to obtain information about the environs of a protein of interest. Proximity proteomics methods developed in the past 10 years depend on fusing the protein of interest to an enzyme that will label nearby proteins with a chemical tag that then can be purified. After purification, mass spectrometry identifies the tagged proteins.

Most often, the chemical tag is biotin, a cofactor that is key to carboxylase enzyme activity in several metabolic pathways. Two types of enzyme are used for proximity-dependent biotinylation: peroxidases, used for methods such as APEX, and biotin ligases, used for methods such as BioID.

Proxprotimage-835x195.jpg
Samavarchi–Tehrani et al./MCP
A schematic diagram shows the proximity proteomics workflow. A bait protein is tagged with a biotinylation enzyme (center of concentric circles), which allows for covalent labeling of proteins in its vicinity with a reactive biotin intermediate. Then the researcher lyses the cells and uses streptavidin to extract biotin-tagged proteins, digests those proteins and uses mass spectrometry to determine their identity.

Ordinarily, biotin ligases append biotin to the carboxylases that need it as a cofactor. Biotin ligases found in cells have high specificity for their substrate proteins, but certain mutations reduce that specificity by decreasing the ligase enzyme’s affinity for a reactive intermediate. Such mutants lose their grip on the cofactor and can release a reactive biotin that can bind the next amine group it encounters — often on a nearby protein. When researchers pull down biotin after this reaction occurs, they can determine what proteins were localized in the neighborhood of the biotin ligase and, by extension, the protein it was tethered to.

The second enzyme family, the peroxidases, evolved to convert hydrogen peroxide to water by redox chemistry. In the presence of a biotin–phenol substrate and hydrogen peroxide, they can make a short-lived free radical that reacts with certain amino acid side chains, once again tagging nearby proteins for later identification.

As proximity proteomics has grown in popularity, both types of enzyme have been the targets of extensive engineering and molecular evolution to coax them toward the activity profiles users want. The authors review the available enzymes and discuss experimental design considerations, such as choice of control conditions and how to get rid of what they call “frequent flyer” proteins that often are isolated nonspecifically.

Enjoy reading 91影库Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from 91影库Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17鈥21 in Cambridge, Massachusetts.